These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 334012)

  • 1. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
    Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
    Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
    Misset JL; Pouillart P; Amiel JL; Schwarzenberg L; Hayat M; de Vassal F; Musset M; Belpomme D; Jasmin C; Albahary C; Depierre R; Mathé G
    Nouv Presse Med; 1975 Dec; 4(44):3117-20. PubMed ID: 768904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
    Lawkowicz W; Polubiec A; Domańska B
    Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 7. Synchronization recruitment chemotherapy in non-Hodgkin hematosarcomas.
    Schneider M; Mancini G; Fella C; Aubanel JM; Hoch M; Viguier E
    Eur J Cancer (1965); 1977; 13(4-5):429-31. PubMed ID: 326556
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 9. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 14. VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
    Chiuten DF; Bennett JM; Creech RH; Glick J; Falkson G; Brodovsky HS; Begg CB; Muggia FM; Carbone PP
    Cancer Treat Rep; 1979 Jan; 63(1):7-11. PubMed ID: 369693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of malignant lymphoma with adriamycin.
    Gottlieb JA; Gutterman JU; McCredie KB; Rodriguez V; Frei E
    Cancer Res; 1973 Nov; 33(11):3024-8. PubMed ID: 4748450
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of the lymphomas.
    McElwain TJ
    Semin Hematol; 1974 Jan; 11(1):59-72. PubMed ID: 4859700
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
    Kühböck J; Pietschmann H
    Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary lymphoblastic lymphoma of the breast.
    Carbone A; Volpe R; Tirelli U; Veronesi A; Galligioni E; Trovo MG; Grigoletto E
    Clin Oncol; 1982 Dec; 8(4):367-73. PubMed ID: 6897770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.